Monday, September 28, 2026

GPRC6A Protein in Cattle: A Multi-Source Evidence Stack from Bull Sperm Proteomics, Mammary Cell Signaling, and Related Domestic Species

The debate around bovine GPRC6A should not be reduced to one figure, one Western blot, or one genome annotation. The stronger way to frame the case is as a layered evidence stack. Some studies detect the protein directly by mass spectrometry. Some detect it by Western blot or immunostaining. Some knock it down and show loss of signaling. Some related-species papers show that the same receptor functions in reproductive endocrinology.

The newly attached article, Singh et al. 2018, is especially useful because it gives independent LC-MS/MS evidence for bovine GPRC6A protein in bull spermatozoa. It does not prove receptor signaling. It does something narrower but valuable: it lists bovine E1BPQ3/GPRC6A as a detected sperm protein.

1. Singh et al. 2018: direct bovine sperm proteomics evidence

Full citation: Singh R, Sengar GS, Singh U, Deb R, Junghare V, Hazra S, Kumar S, Tyagi S, Das AK, Raja TV, Kumar A. 2018. “Functional proteomic analysis of crossbred (Holstein Friesian × Sahiwal) bull spermatozoa.” Reproduction in Domestic Animals 53:588–608. DOI: 10.1111/rda.13146.

The article’s central proteomics claim is that “A total of 1,547 proteins” were detected in bull spermatozoa by LC-MS/MS. The same abstract says the study compared good and poor fertility semen and identified proteins linked to motility, immunity, and metabolism.

The methods matter. The authors digested sperm proteins with trypsin, separated peptides on a C18 UPLC column, analyzed them on a Waters Synapt G2 Q-TOF instrument, and matched MS/MS spectra to database sequences using PLGS software.

GPRC6A evidence: Table 3 lists E1BPQ3, annotated as “G protein-coupled receptor family C group 6 member A,” Bos taurus, GN = GPRC6A, with PLG score 52.72 and good-vs-poor ratio 0.794534.

Figure details: Figure 2 shows a representative LC-MS-IT-TOF total ion chromatogram, the instrumental anchor for the proteomics workflow. Figure 3 shows the distribution of proteins in good and poor quality bull spermatozoa, including 558 good-specific proteins, 653 poor-specific proteins, and 336 shared proteins.

How to use this paper: This is not a GPRC6A pathway study. It does not show ligand binding, localization, knockdown, or signaling. But it is strong protein-existence evidence because GPRC6A is detected by a technology independent of antibodies.

2. Li et al. 2019: bovine BMEC lysine pathway evidence

Full citation: Li X, Li P, Wang L, Zhang M, Gao X. 2019. “Lysine Enhances the Stimulation of Fatty Acids on Milk Fat Synthesis via the GPRC6A-PI3K-FABP5 Signaling in Bovine Mammary Epithelial Cells.” Journal of Agricultural and Food Chemistry 67(25):7005–7015. DOI: 10.1021/acs.jafc.9b02160.

This paper is one of the strongest cow-specific functional studies. The abstract states that lysine stimulates FABP5 through GPRC6A-PI3K signaling and affects GPRC6A expression and plasma-membrane localization.

Key exact text: the paper reports that GPRC6A knockdown “totally abolished Lys-stimulated PI3K phosphorylation.”

Figure details: Figure 7 is the functional heart of the paper. Panel A is a Western blot after lysine, fatty acids, and GPRC6A siRNA treatment. Panel B quantifies GPRC6A knockdown. Panel C quantifies p-PI3K/PI3K. Panels D to F quantify FABP5, SREBP-1c, and nuclear SREBP-1c.

Figure 8 then shows receptor-level support: GPRC6A Western blotting, quantification, immunofluorescence localization, DAPI staining, 15 μm scale bar, and ImageJ AIOD quantification. The text says GPRC6A was located at the plasma membrane and lysine had a maximal effect at 0.70 mM.

How it complements Singh et al.: Singh gives mass-spec detection in sperm. Li gives receptor-pathway causality in bovine mammary epithelial cells. One says the protein exists in bovine sperm; the other says reducing GPRC6A disrupts lysine-dependent signaling in bovine mammary cells.

3. Jin et al. 2022: bovine BMEC palmitic-acid pathway evidence

Full citation: Jin X, Zhen Z, Wang Z, Gao X, Li M. 2022. “GPRC6A is a key mediator of palmitic acid regulation of lipid synthesis in bovine mammary epithelial cells.” Cell Biology International 46(11):1747–1758. DOI: 10.1002/cbin.11886.

This is another very strong bovine functional paper. The abstract reports that GPRC6A knockdown blocked palmitic-acid stimulation of PI3K and PKCα phosphorylation, SREBP-1c expression and maturation, and that palmitic acid promoted GPRC6A expression and membrane localization.

Key exact text: the paper says GPRC6A knockdown “almost totally blocked” PA stimulation of PI3K and PKCα activation.

Figure details: Figure 6 tests GPRC6A knockdown. Panel A is a Western blot after 100 μM palmitic acid and GPRC6A siRNA. Panel B quantifies GPRC6A. Panels C and D quantify p-PI3K/PI3K and p-PKCα/PKCα. Panels E and F quantify full-length and nuclear SREBP-1c. Panel G measures secreted triglycerides.

Figure 7 tests receptor regulation and localization. Panel A measures GPRC6A protein by Western blot. Panel B quantifies it. Panel C shows GPRC6A immunofluorescence, with GPRC6A in green and DAPI in blue. Panel D quantifies AIOD per cell. The scale bar is 25 μm.

How it complements Singh et al.: Singh detects GPRC6A by LC-MS/MS in bull sperm. Jin shows that, in bovine mammary cells, GPRC6A is not just detectable but functionally upstream of PI3K, PKCα, SREBP-1c, and triglyceride secretion.

4. Zhang et al. 2025: live dairy cow in vivo mammary evidence

Full citation: Zhang J, Lang J, Bu L, Liu Y, Huo W, Pei C, Liu Q. 2025. “Impacts of dietary arginine supplementation on performance, nutrient digestion and expression of proteins related to milk fatty acid and casein synthesis in early lactating dairy cows.” Animal Nutrition 21:267–278. DOI: 10.1016/j.aninu.2024.10.010.

This paper is important because it is in vivo in lactating dairy cows. Forty-eight multiparous Chinese Holstein cows were assigned to control, 20 g/day, 40 g/day, or 60 g/day arginine as rumen-protected arginine.

Key exact text: the Results state that “GPRC6A, p-Akt/Akt, and p-mTOR/mTOR” increased with arginine provision.

Figure details: Figure 2 is the GPRC6A figure. Panel A is a Western blot for GPRC6A, Akt, p-Akt, mTOR, and p-mTOR in bovine mammary glands from control and 40 g/day arginine cows. Panel B quantifies GPRC6A, p-Akt/Akt, and p-mTOR/mTOR, with values standardized to control and significance marked at P < 0.01.

The conclusion states that RPArg activates the GPRC6A-Akt/mTOR pathway and promotes proteins connected with cell proliferation, milk fatty-acid synthesis, and milk-protein synthesis.

How it complements Singh et al.: Zhang adds whole-animal mammary evidence. It is weaker than knockdown evidence because it is associative, but it is stronger physiologically because it comes from live cows.

5. Yu et al. 2019: negative taurine-pathway evidence, but useful GPRC6A protein evidence

Full citation: Yu M, Wang Y, Wang Z, Liu Y, Yu Y, Gao X. 2019. “Taurine Promotes Milk Synthesis via the GPR87-PI3K-SETD1A Signaling in BMECs.” Journal of Agricultural and Food Chemistry 67(7):1927–1936. DOI: 10.1021/acs.jafc.8b06532.

This paper must be framed honestly. It does not show that GPRC6A mediates taurine signaling. It shows the opposite. The positive receptor is GPR87.

However, it is still valuable because the authors test GPRC6A by Western blot and siRNA. They had no incentive to force GPRC6A into the pathway, because their final mechanism excludes it.

Key exact text: the Results say GPRC6A knockdown “did not suppress PI3K activation” after taurine stimulation.

Figure details: Figure 7A is the GPRC6A test: BMECs were transfected with GPRC6A siRNA and treated with 0.24 mM taurine for 24 hours, followed by Western blotting. Figures 7B to 7F are the GPR87 knockdown and quantification panels.

The methods list the GPRC6A antibody and the GPRC6A siRNA sequence, giving the experiment a concrete protein-detection and perturbation basis.

How it complements Singh et al.: Singh gives mass-spec protein detection. Yu gives antibody detection plus siRNA behavior, but in a negative pathway context. That negative context actually makes the GPRC6A protein band harder to dismiss as story-driven decoration.

6. Leites et al. 2026 / PXD066938: bull sperm proteomics reanalysis evidence

Full citation: Leites I, Diniz P, Fardilha M, Santiago J, Ferreira-Dias G, Lopes-da-Costa L, Silva E. 2026. “Proteomic dynamics of bull sperm during post-testicular maturation.” BMC Genomics 27:281. DOI: 10.1186/s12864-026-12614-0. The associated ProteomeXchange dataset is PXD066938.

This study profiled bull testicular, caput epididymal, and cauda epididymal spermatozoa using shotgun proteomics. It reported 2,305 quantified proteins in testicular sperm, 2,554 in caput sperm, and 2,038 in cauda sperm.

Figure details: Figure 1 shows PCA, Venn analysis, and UniProt protein-existence categories across sperm populations. Figure 2 shows proteome remodeling during epididymal transit, using gained and lost protein diagrams. Figure 7 compares conserved bull epididymal sperm proteins with mouse, ram, and pig datasets.

The authors deposit the mass-spectrometry data through PRIDE under PXD066938.

GPRC6A-specific note: A later reanalysis reports that PXD066938 contains the bovine GPRC6A peptide NDVFIVTNQETK, mapping to UniProt E1BPQ3. This is promising, but I would treat it as a reanalysis claim until the peptide is directly verified in the PRIDE result files.

How it complements Singh et al.: Singh gives a Table 3 protein-level GPRC6A call. PXD066938 potentially gives a specific peptide barcode, NDVFIVTNQETK, in an independent bull sperm dataset. If verified directly, it becomes the cleanest bovine sperm proteomics support.

7. Sagdiev et al. 2022: bovine colostrum low-abundance peptide evidence, but weaker

Full citation: Sagdiev NJ, Ziyavitdinov JF, Berdiev NS, Bozorov SS, Khudoyberdiev TA, Olimjonov SS, Vypova NL, Asrorov AM. 2022. “Low abundant bovine colostrum proteins in combination with amaranth oil reveal topical analgesic activity.” Nova Biotechnologica et Chimica 21(1):e1246. DOI: 10.36547/nbc.1246.

This paper reports mass-spectrometry identification of partial sequences from low-abundance bovine colostrum proteins. The abstract states that 37 identified proteins had partial sequences established by mass spectrometry and BLAST search.

GPRC6A-specific text: Table 2 lists SDKIHFPS, accession E1BPQ3.1, query cover 100%, identity 87.5%, annotated as “G-protein coupled receptor family C gr. 6 member A.”

Figure/table details: The GPRC6A evidence is not in a figure. It is in Table 2, which lists identified low-abundance bovine colostrum sequences, accession numbers, query cover, percent identity, and NCBI annotation.

How it complements Singh et al.: It adds a mammary secretion context, colostrum, but it is weaker because the peptide is only eight amino acids and differs from the canonical bovine sequence we checked earlier, where the analogous motif is SDKIQFPS, not SDKIHFPS. Treat this one as supportive but low-confidence unless the spectrum and database entry are rechecked.

8. Bharath Kumar et al. 2024: buffalo Leydig-cell receptor localization and steroidogenesis

Full citation: Bharath Kumar BS, Mallick S, Manjunathachar HV, Shashank CG, Sharma A, Nagoorvali D, Soren S, Jadhav VG, Pandita S. 2024. “In vitro effects of uncarboxylated osteocalcin on buffalo Leydig cell steroidogenesis.” Veterinary Research Communications 48(3):1423–1433. DOI: 10.1007/s11259-024-10320-4.

This is buffalo, not cow, but it is a close domestic bovine relative and directly relevant to GPRC6A reproductive biology.

Key exact text: the abstract says immunostaining confirmed “the presence of GPRC6A receptors.”

Figure details: Figure 5 shows GPRC6A receptor localization in buffalo Leydig cells. The caption specifies primary antibody GPRC6A, omitted-primary control, Hoechst nuclear staining, FITC secondary antibody, merged images, 20× magnification, and 100 μm scale bar.

Figure 6 measures testosterone in culture medium after UcOCN and LH stimulation. The highest UcOCN response was at 6 ng/ml, with testosterone rising to 1.81 ± 0.17 ng/10⁶ cells/24 h.

Figure 7 measures CYP11A1, CYP17A1, HSD3β1, and HSD3β6 expression after 6 ng/ml UcOCN and 0.5 ng/ml LH.

How it complements cow evidence: It supports the conservation of a GPRC6A-positive Leydig-cell axis in a bovine relative. It is weaker than cow BMEC knockdown papers because it does not block GPRC6A, but it is strong localization plus ligand-response evidence.

9. Yang et al. 2025: porcine Leydig-cell receptor mechanism

Full citation: Yang G, Liu H, Yin Z, Zhao L, Chen Y, Li Y, Cheng L, Ma J, Yu J, Zhang Y, Li X, Li R. 2025. “ucOCN Promotes Testosterone Synthesis via the PKA-MAPK/ERK-CREB Signaling Pathway in Porcine Leydig Cells.” Cells 14(24):1937. DOI: 10.3390/cells14241937.

This is not bovine, but it is one of the strongest related-domestic-mammal GPRC6A papers.

Key exact text: the paper states that GPRC6A “physically interacts with ucOCN” in porcine Leydig cells.

Figure details: Figure 1C shows GPRC6A expression on the plasma membrane. Figure 1D shows molecular docking of GPRC6A and osteocalcin. Figure 1E shows Co-IP confirming GPRC6A-ucOCN interaction. Figure 1F and 1G show phosphorylation of PKA, MEK, ERK, and CREB. Figure 1H and 1I measure testosterone and cAMP.

Figure 2 tests GPRC6A knockdown. Panel A shows Western blots for PKA, MEK, ERK, and CREB phosphorylation after ucOCN with or without GPRC6A knockdown. Panel C measures testosterone. Panel D measures steroidogenic genes. Panel E measures cAMP. Panels F and G show immunofluorescence for STAR, HSD3B1, CYP11A1, and CYP17A1.

How it complements cow evidence: This is not a cow paper, so it cannot replace bovine evidence. But it shows that in a domestic artiodactyl, GPRC6A can be a bona fide receptor with membrane localization, Co-IP interaction, cAMP signaling, knockdown sensitivity, and hormone output.

10. Ge et al. 2022: mouse mammary GPRC6A pathway support

Full citation: Ge Y, Li F, He Y, Cao Y, Guo W, Hu G, Liu J, Fu S. 2022. “L-arginine stimulates the proliferation of mouse mammary epithelial cells and the development of mammary gland in pubertal mice by activating the GPRC6A/PI3K/AKT/mTOR signalling pathway.” Journal of Animal Physiology and Animal Nutrition 106(6):1383–1395. DOI: 10.1111/jpn.13730.

This paper matters because Zhang et al. 2025 explicitly use it to interpret the bovine RPArg result. Zhang et al. state that arginine links GPRC6A with Akt/mTOR and that Ge et al. found arginine activation of Akt was inhibited after GPRC6A knockdown.

Key exact text from accessible abstract: GPRC6A knockdown or PI3K/AKT/mTOR inhibition “completely abolished” arginine-induced proliferation in mouse mammary epithelial cells.

Figure details: I could verify the abstract and citation details, but the accessible Wiley page did not expose exact figure captions through the browser. So I would not claim exact panel structure without the full PDF.

How it complements cow evidence: It supports the mammary GPRC6A/arginine/Akt/mTOR model that Zhang et al. then tests in dairy cows at the protein-expression level.

11. Oury et al. 2013: foundational mouse and human GPRC6A fertility evidence

Full citation: Oury F, Ferron M, Huizhen W, Confavreux C, Xu L, Lacombe J, Srinivas P, Chamouni A, Lugani F, Lejeune H, Kumar TR, Plotton I, Karsenty G. 2013. “Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis.” Journal of Clinical Investigation 123(6):2421–2433. DOI: 10.1172/JCI65952. Note: later corrigenda corrected details of the human GPRC6A variant localization.

This is foundational mammalian GPRC6A biology. The abstract states that osteocalcin promotes testosterone biosynthesis by binding GPRC6A in Leydig cells.

Figure details: Figure 2 compares WT, osteocalcin-deficient, and Gprc6a-deficient mice after PBS, hCG, or osteocalcin injections. It includes sperm count, reproductive-organ weights, and testosterone levels.

Figure 7 analyzes a human GPRC6A missense variant associated with decreased fertility. It includes mutation mapping, immunofluorescence of WT and mutant GPRC6A in HEK293T cells, cAMP production after osteocalcin, qPCR/Western blot expression controls, and StAR/steroidogenic gene readouts.

The corrigendum clarifies that the F464Y variant is in the long N-terminal domain and prevented localization to the cell membrane.

How it complements cow evidence: It supplies the broader mammalian receptor biology. The cow and buffalo papers become more plausible because they fit a previously established GPRC6A-Leydig and GPRC6A-nutrient signaling framework.

Comparative interpretation

The evidence should be ranked like this:

SourceSpecies and tissueEvidence typeStrength for GPRC6A protein/function
Singh et al. 2018Crossbred bull spermLC-MS/MS, Table 3 E1BPQ3/GPRC6AStrong protein-existence evidence, not functional
PXD066938 / Leites et al. 2026Bull testicular/caput/cauda spermShotgun proteomics, reported peptide NDVFIVTNQETK in reanalysisPotentially strong peptide evidence, needs direct PRIDE table verification
Sagdiev et al. 2022Bovine colostrumPartial peptide SDKIHFPS assigned to E1BPQ3.1Weak to moderate, short peptide and sequence mismatch caution
Yu et al. 2019Bovine BMECsWestern blot plus GPRC6A siRNAStrong protein-detection/knockdown evidence, negative for taurine pathway
Li et al. 2019Bovine BMECsGPRC6A knockdown, WB, IF, PI3K/FABP5/SREBP-1cVery strong bovine functional evidence
Jin et al. 2022Bovine BMECsGPRC6A knockdown, WB, IF, PI3K/PKCα/SREBP-1c/TGVery strong bovine functional evidence
Zhang et al. 2025Live dairy cow mammary glandWestern blot for GPRC6A and Akt/mTORStrong in vivo association, not direct causality
Bharath Kumar et al. 2024Buffalo Leydig cellsGPRC6A IF, testosterone ELISA, qPCRStrong related-bovine localization plus ligand response
Yang et al. 2025Pig Leydig cellsGPRC6A membrane IF, Co-IP, cAMP, siRNA, testosteroneVery strong related-species mechanism
Ge et al. 2022Mouse mammary glandGPRC6A knockdown plus PI3K/AKT/mTOR pathwayStrong mammary model support
Oury et al. 2013Mouse/human Leydig axisgenetics, receptor localization, cAMP, fertility phenotypeFoundational mammalian support

Clean final argument

The Singh et al. 2018 paper should be used for this claim:

Bovine GPRC6A protein, UniProt E1BPQ3, was detected in crossbred bull spermatozoa by LC-MS/MS and listed in Table 3 of a comparative sperm proteomics study.

That claim is narrow, but sturdy.

It complements the broader GPRC6A case beautifully:

Singh et al. gives the mass-spec footprint in bull sperm.
Li and Jin give the causal mammary-cell signaling evidence.
Yu gives an honest negative-pathway but positive-protein control.
Zhang gives live cow mammary-gland protein association.
Leites/PXD066938 may give an independent peptide barcode in bull sperm.
Buffalo and pig Leydig-cell papers show that GPRC6A receptor biology is conserved in related domestic mammals.

So the honest blog conclusion is:

No single paper proves everything. But together, the evidence argues that bovine GPRC6A is not merely a genome annotation. It is detected as protein by LC-MS/MS in bull sperm, detected and perturbed by Western blot/siRNA in bovine mammary epithelial cells, associated with Akt/mTOR signaling in live cow mammary gland, and functionally supported by closely related domestic species. The strongest bovine functional evidence remains Li et al. 2019 and Jin et al. 2022; the strongest independent proteomic existence evidence is Singh et al. 2018, with PXD066938 as a promising peptide-level follow-up.

Sunday, September 27, 2026

A Negative Pathway Result That Strengthens the Evidence for GPRC6A Protein in Cow

In biology, a negative result can sometimes be surprisingly valuable. A paper may test a gene, decide it is not part of the pathway under study, and in doing so provide unusually credible evidence that the gene’s protein product exists in the experimental system. That is exactly the case for GPRC6A in the bovine mammary epithelial cell paper:

“Taurine Promotes Milk Synthesis via the GPR87-PI3K-SETD1A Signaling in BMECs.”

The paper was authored by Mengmeng Yu, Yang Wang, Zhe Wang, Yanxu Liu, Yang Yu, and Xuejun Gao, with affiliations at Agricultural College of Guangdong Ocean University and The Key Laboratory of Dairy Science of Education Ministry, Northeast Agricultural University. It was published in the Journal of Agricultural and Food Chemistry in 2019, volume 67, pages 1927 to 1936, DOI 10.1021/acs.jafc.8b06532.

The headline conclusion of the paper is not about GPRC6A. The authors conclude that taurine promotes milk synthesis through GPR87-PI3K-SETD1A signaling. In the abstract, they state that gene-function approaches revealed GPR87-PI3K-SETD1A signaling was required for taurine to increase mTOR and SREBP-1c mRNA levels, and that taurine stimulated GPR87 expression and membrane localization.

But this is precisely why the GPRC6A result is interesting.

The authors did not build their story around GPRC6A. They tested GPRC6A as a plausible candidate receptor, knocked it down, found that taurine signaling still occurred, and then moved the pathway to GPR87. That makes the GPRC6A Western blot evidence less likely to be a pathway-confirmation artifact. The GPRC6A band was not needed to sell the final mechanism. In fact, the final mechanism explicitly excludes GPRC6A from taurine signaling.

Why GPRC6A was tested at all

The authors had a strong biological reason to consider GPRC6A. In the introduction, they explain that some GPCRs can sense extracellular amino acids and activate downstream signaling such as PI3K/mTOR. They specifically name GPRC6A as one of these amino-acid-sensing GPCRs.

They also state in the Results that previous mass-spectrometric data showed both GPRC6A and GPR87 were upregulated in BMECs treated with methionine. Therefore, they hypothesized that GPRC6A, GPR87, or both might be required for taurine-induced PI3K activation.

This gives the experiment a clean logic:

Taurine activates PI3K. GPRC6A and GPR87 are candidate GPCRs. Knock each down. See which one matters.

The key assay: Western blot detection of GPRC6A protein

The paper’s Methods section lists a specific antibody for GPRC6A detection: GPRC6A antibody ab138994 from Abcam. The same Western blot workflow also used antibodies against GPR87, SETD1A, H3K4Me3, PI3K pathway proteins, mTOR, SREBP-1c, and β-actin. The signals were visualized by chemiluminescence, quantified in ImageJ, and normalized to β-actin or histone H3.

This matters because the paper is not only mentioning GPRC6A in text. It directly measures a GPRC6A protein band by Western blot.

The strongest GPRC6A evidence: siRNA knockdown in Figure 7A

The crucial figure is Figure 7A.

In Figure 7A, BMECs were transfected with GPRC6A siRNA and treated with 0.24 mM taurine for 24 hours. The figure caption explicitly states that cells were transfected with GPRC6A siRNA and then analyzed by Western blot.

The Methods section gives the exact GPRC6A siRNA sequence used:

GPRC6A-siRNA: 5′-GCUCUGAGGUGUGUUUCUATT-3′.

This is important because the experiment is not simply “we saw a band and named it GPRC6A.” The authors used a targeted knockdown reagent against GPRC6A and then observed the Western blot signal under knockdown conditions.

That provides two layers of evidence:

  1. Baseline detection: a GPRC6A protein band is detectable in bovine mammary epithelial cells.
  2. Knockdown validation: the GPRC6A band is reduced after GPRC6A siRNA treatment.

This makes the protein-level evidence much stronger than a standalone antibody blot. A Western blot band that decreases after gene-specific siRNA behaves like the intended protein signal. It is not perfect proof, but it is one of the more persuasive practical validations used in cell-biology papers.

What Figure 7A actually shows

Figure 7A tests whether GPRC6A is required for taurine-induced PI3K activation.

The result is beautifully paradoxical for our purpose.

The authors report that GPRC6A knockdown did not suppress PI3K activation after taurine stimulation. In their interpretation, this means GPRC6A is not required for taurine to activate PI3K.

So Figure 7A says two things at once:

First: GPRC6A protein is detectable and knockdown-able in bovine BMECs.
Second: GPRC6A is not the receptor responsible for taurine-to-PI3K signaling.

That distinction is the whole treasure chest.

If the authors wanted to force a GPRC6A pathway story, Figure 7A would have been inconvenient. Instead, they used it to eliminate GPRC6A and support GPR87.

Why the negative result makes the GPRC6A blot more credible

One has to be careful here: we cannot know the authors’ intentions. But we can evaluate the evidentiary structure.

The GPRC6A Western blot is not being used to claim that GPRC6A mediates taurine signaling. The paper’s main pathway is GPR87, not GPRC6A. The Results section states that GPRC6A knockdown did not block taurine-induced PI3K activation, while GPR87 knockdown largely abolished taurine effects on p-PI3K, p-mTOR, and SREBP-1c.

The Discussion says this even more directly: “GPR87 but not GPRC6A” knockdown abolished taurine’s stimulatory effects on PI3K and downstream signaling.

That makes the GPRC6A detection valuable in a special way. The authors had no pathway-level incentive to exaggerate GPRC6A as functional in taurine signaling, because their conclusion goes the other way. Yet they still show a GPRC6A Western blot band and use GPRC6A siRNA in Figure 7A.

In other words, the GPRC6A signal is not decorative confetti thrown over the main claim. It is part of a receptor-exclusion experiment.

The contrast with GPR87 sharpens the argument

The paper’s positive receptor is GPR87.

In Figure 7B to 7F, GPR87 knockdown reduces GPR87 protein and blocks taurine-induced p-PI3K, p-mTOR, and SREBP-1c responses. The figure caption describes the GPR87 knockdown Western blots and quantification of GPR87, p-PI3K/PI3K, p-mTOR/mTOR, and SREBP-1c.

That contrast matters.

The authors did not merely say, “GPRC6A exists.” They ran a comparative receptor screen:

GPRC6A knockdown: taurine signaling survives.
GPR87 knockdown: taurine signaling collapses.

This makes the GPRC6A experiment a clean negative control against the GPR87 result.

But for protein existence, the GPRC6A portion remains valuable because it demonstrates that the GPRC6A protein signal was measurable and experimentally reducible in bovine cells.

What this paper can honestly be used to claim

This paper should not be cited as evidence that GPRC6A mediates taurine-induced milk synthesis. It says the opposite.

But it can be cited as strong evidence for this narrower claim:

Bovine mammary epithelial cells contain a detectable GPRC6A protein signal by Western blot, and this signal is reduced by GPRC6A-targeting siRNA.

That is a meaningful protein-level validation.

The strongest honest wording would be:

Yu et al. tested GPRC6A as a candidate taurine receptor in bovine mammary epithelial cells. Although GPRC6A knockdown did not block taurine-induced PI3K activation, Figure 7A provides protein-level evidence that GPRC6A is detectable by Western blot in BMECs and that the detected signal is responsive to GPRC6A siRNA knockdown. Thus, the paper is negative evidence for GPRC6A in taurine signaling, but positive evidence for the existence of GPRC6A protein in cow mammary epithelial cells.

Why this matters for bovine GPRC6A functionality

Functional annotation often asks several different questions:

  1. Is the gene present in the genome?
  2. Is the transcript expressed?
  3. Is the protein product detectable?
  4. Is the protein part of a biological pathway?
  5. Is it required for a particular phenotype?

This taurine paper helps mainly with question 3.

It does not show that GPRC6A mediates taurine signaling. It does not establish direct ligand binding. It does not prove a GPRC6A-dependent taurine phenotype. But it does show a GPRC6A protein band in bovine BMECs and a targeted knockdown experiment that reduces the band.

For the broader cow GPRC6A argument, this paper should be used as a brick, not the whole barn.

Together with other bovine papers where GPRC6A knockdown blocks lysine or palmitic-acid signaling, this taurine paper adds an independent piece of evidence: even in a pathway where GPRC6A is ruled out, the protein is still detected and experimentally manipulated.

That is why this paper is useful. Not because it makes GPRC6A the taurine receptor, but because it shows that GPRC6A was present enough, measurable enough, and knockdown-able enough to be tested and rejected.

Final interpretation

The most honest conclusion is:

This paper provides strong evidence for the existence of GPRC6A protein in bovine mammary epithelial cells, based on Western blot detection and siRNA knockdown validation in Figure 7A. However, it does not support GPRC6A as part of the taurine-induced milk-synthesis pathway. Instead, the authors use the GPRC6A knockdown result to exclude it and identify GPR87 as the functional taurine-responsive receptor.

That is not a weakness. It is exactly why the GPRC6A protein evidence is persuasive.

The paper clears GPRC6A from the taurine pathway, but in doing so, it leaves behind a useful fingerprint: GPRC6A protein exists in cow mammary epithelial cells and can be detected by Western blot. 🐄

Saturday, September 26, 2026

Variance and Standard Deviation: Why Squaring Won

Variance occupies a privileged position in statistics.

Why?

Not because squaring deviations is intuitively inevitable.

It is because squared deviations have extraordinarily convenient mathematics.


1. Population variance

For a random variable (X),

E[(X-\mu)^2].
]

Expanding,

X^2-2\mu X+\mu^2.
]

Taking expectations,

E[X^2]-2\mu E[X]+\mu^2.
]

Since

[
E[X]=\mu,
]

we obtain

[
\boxed{
\operatorname{Var}(X)=E[X^2]-E[X]^2
}
]

This identity makes variance enormously convenient computationally and theoretically.


2. Why deviations are measured around the mean

Consider

[
L(c)=\sum_i(x_i-c)^2.
]

Differentiate:

-2\sum_i(x_i-c).
]

Set this equal to zero:

[
\sum_i(x_i-c)=0.
]

Therefore,

[
nc=\sum_i x_i
]

and hence

[
c=\bar{x}.
]

So the arithmetic mean is precisely the value that minimizes total squared deviation.

By contrast, the median minimizes total absolute deviation.

This gives us a beautiful duality:

[
L_2 \text{ loss} \rightarrow \text{mean}
]

[
L_1 \text{ loss} \rightarrow \text{median}.
]


3. Sample variance and (n-1)

For a sample,

\frac{1}{n-1}
\sum_i(x_i-\bar{x})^2.
]

Why (n-1)?

Because after estimating the sample mean, only (n-1) deviations are free.

Indeed,

[
\sum_i(x_i-\bar{x})=0.
]

Once (n-1) deviations are known, the last is determined.

More formally,

\frac{n-1}{n}\sigma^2.
]

Dividing by (n-1) instead removes this downward bias for estimating population variance.


4. Why standard deviation exists

Variance has squared units.

If height is measured in centimeters,

[
\operatorname{Var}(X)
]

has units of

[
\text{cm}^2.
]

Taking the square root produces

[
SD=\sqrt{\operatorname{Var}(X)},
]

which returns us to centimeters.

That makes standard deviation substantially easier to communicate.


5. Python demonstration

import numpy as np

x = np.array([4, 5, 5, 6, 10])

print("Population variance:",
      np.var(x, ddof=0))

print("Sample variance:",
      np.var(x, ddof=1))

print("Sample SD:",
      np.std(x, ddof=1))

Verify the alternative variance formula:

var1 = np.mean(
    (x - np.mean(x))**2
)

var2 = np.mean(x**2) - np.mean(x)**2

print(var1, var2)

6. R demonstration

x <- c(4, 5, 5, 6, 10)

# R's var() uses denominator n - 1
var(x)
sd(x)

# Population variance
mean((x - mean(x))^2)

# Computational identity
mean(x^2) - mean(x)^2

7. Variances add

One of variance's greatest mathematical advantages is:

\operatorname{Var}(X)
+\operatorname{Var}(Y)
+2\operatorname{Cov}(X,Y).
]

If (X) and (Y) are independent,

[
\operatorname{Cov}(X,Y)=0
]

and therefore

\operatorname{Var}(X)
+
\operatorname{Var}(Y).
]

Standard deviations do not enjoy such a clean decomposition.

This property helped make variance foundational in experimental design, quantitative genetics, measurement theory, and signal processing.

Fisher's 1918 work made variance decomposition central to statistical thinking.


8. Variance's Achilles heel

Variance squares deviations.

Suppose our data are:

[
1,2,3,4,5.
]

Now replace 5 with 100.

import numpy as np

a = np.array([1,2,3,4,5])
b = np.array([1,2,3,4,100])

print(np.var(a, ddof=1))
print(np.var(b, ddof=1))

The variance explodes.

In fact, classical variance has a breakdown point effectively approaching zero: one sufficiently extreme observation can make it arbitrarily large.

This motivates an entirely different branch of statistics.

Robust statistics.

Friday, September 25, 2026

Range, IQR, and Absolute Deviations

Before reaching variance, it is worth exploring measures that are often simpler and sometimes more appropriate.


1. Range

The range is

[
R=x_{\max}-x_{\min}.
]

For

[
2,;3,;4,;5,;6
]

the range is

[
6-2=4.
]

Its greatest advantage is interpretability.

Its greatest weakness is equally obvious.

Only two observations determine it.

A dataset containing one million observations has its range determined entirely by its minimum and maximum.


2. Interquartile range

The interquartile range is

[
IQR=Q_3-Q_1.
]

It describes the width occupied by the middle half of the observations.

Because observations below (Q_1) and above (Q_3) do not directly affect the endpoints, it is much less sensitive to extremes than the range or standard deviation.

That makes the IQR especially useful for skewed distributions.

It is also the machinery behind the familiar boxplot.


3. Mean absolute deviation

Instead of squaring deviations, why not simply take their absolute values?

Around the mean:

\frac1n
\sum_{i=1}^{n}|x_i-\bar x|.
]

Or around the median:

\frac1n
\sum_{i=1}^{n}|x_i-\tilde x|.
]

These should not be confused with the median absolute deviation, which we will encounter later.

Absolute deviations have a useful property: extreme observations grow linearly rather than quadratically in influence.

Consider deviations of 2 and 20.

Under absolute loss:

[
2 \rightarrow 2,\qquad 20\rightarrow20.
]

Under squared loss:

[
2\rightarrow4,\qquad20\rightarrow400.
]

Squaring turns the second observation into a statistical megaphone.


4. Python comparison

import numpy as np
import pandas as pd

x = np.array([10, 11, 12, 13, 14, 15, 50])

mean = np.mean(x)
median = np.median(x)

results = {
    "Range": np.ptp(x),
    "IQR": np.percentile(x, 75)
           - np.percentile(x, 25),
    "Mean abs dev about mean":
        np.mean(np.abs(x - mean)),
    "Mean abs dev about median":
        np.mean(np.abs(x - median)),
    "SD": np.std(x, ddof=1)
}

print(pd.Series(results))

Now progressively increase the outlier.

outliers = np.arange(15, 101, 5)

rows = []

for o in outliers:
    z = np.array([10, 11, 12, 13, 14, 15, o])

    rows.append({
        "outlier": o,
        "range": np.ptp(z),
        "IQR": np.percentile(z, 75)
               - np.percentile(z, 25),
        "SD": np.std(z, ddof=1),
        "AAD": np.mean(
            np.abs(z - np.mean(z))
        )
    })

df = pd.DataFrame(rows)
print(df)

Plot the trajectories:

import matplotlib.pyplot as plt

plt.plot(df["outlier"], df["range"],
         label="Range")
plt.plot(df["outlier"], df["SD"],
         label="SD")
plt.plot(df["outlier"], df["IQR"],
         label="IQR")
plt.plot(df["outlier"], df["AAD"],
         label="Absolute deviation")

plt.xlabel("Extreme observation")
plt.ylabel("Dispersion")
plt.legend()
plt.show()

This plot is wonderfully revealing.

Range grows directly with the extreme observation.

SD grows rapidly.

Absolute deviation responds more gently.

IQR barely notices.


5. R version

x <- c(10, 11, 12, 13, 14, 15, 50)

aad_mean <- mean(abs(x - mean(x)))
aad_median <- mean(abs(x - median(x)))

c(
  Range = diff(range(x)),
  IQR = IQR(x),
  AAD_mean = aad_mean,
  AAD_median = aad_median,
  SD = sd(x)
)

Simulation:

outliers <- seq(15, 100, by = 5)

result <- data.frame(
  outlier = outliers,
  range = NA,
  IQR = NA,
  SD = NA,
  AAD = NA
)

for (i in seq_along(outliers)) {
  z <- c(10, 11, 12, 13, 14, 15,
         outliers[i])

  result$range[i] <- diff(range(z))
  result$IQR[i] <- IQR(z)
  result$SD[i] <- sd(z)
  result$AAD[i] <- mean(abs(z - mean(z)))
}

matplot(
  result$outlier,
  result[, c("range", "IQR", "SD", "AAD")],
  type = "l",
  lty = 1,
  xlab = "Extreme observation",
  ylab = "Dispersion"
)

legend(
  "topleft",
  legend = c("Range", "IQR", "SD", "AAD"),
  lty = 1,
  col = 1:4
)

6. Advantages and limitations

MeasureStrengthMain limitation
RangeExtremely intuitiveDetermined by two observations
IQRRobust and easy to interpretIgnores much tail information
Mean absolute deviationSame units and moderate tail sensitivityLess algebraically convenient
SDRich mathematical theoryHighly sensitive to tails

A useful habit is to report more than one.

For skewed or contamination-prone data, reporting

[
\text{median + IQR}
]

may be far more informative than

[
\text{mean + SD}.
]

Wednesday, September 23, 2026

What Does "Spread" Actually Mean?

 

1. Location is only half the story

Suppose two laboratories measure the same quantity.

Laboratory A reports:

[
10,;10,;10,;10,;10
]

Laboratory B reports:

[
2,;6,;10,;14,;18
]

Both have mean 10.

Yet describing them as statistically equivalent would clearly be absurd.

A location statistic tells us where the distribution sits.

A dispersion statistic tells us how broadly the observations occupy the space around that location.

This distinction appears everywhere:

  • biology: variability in gene expression,
  • ecology: variability in species abundance,
  • manufacturing: process consistency,
  • finance: volatility,
  • medicine: heterogeneity of patient responses,
  • genomics: read depth variability,
  • machine learning: variability of representations or prediction uncertainty.

Sometimes variability is noise.

Sometimes variability is the biological phenomenon.

That distinction matters enormously.


2. Four different ideas of dispersion

Consider:

[
x=(1,2,3,4,20).
]

There are several reasonable ways to describe its spread.

Extreme separation

[
\text{Range}=\max(x)-\min(x)
]

This asks:

How far apart are the most extreme observations?

Central spread

[
IQR=Q_{0.75}-Q_{0.25}
]

This asks:

How wide is the middle 50%?

Typical deviation from a center

For example,

[
\frac{1}{n}\sum |x_i-\bar{x}|
]

or

[
\operatorname{median}|x_i-\operatorname{median}(x)|.
]

These ask:

How far does a typical observation lie from some center?

Pairwise spread

We can instead ask how far apart observations are from one another:

[
\frac{1}{\binom n2}
\sum_{i<j}|x_i-x_j|.
]

This idea leads to Gini's mean difference.

None of these questions is inherently more correct than the others.

They simply measure different geometries of variability.


3. A short historical detour

The modern vocabulary emerged gradually.

Karl Pearson introduced the term standard deviation in lectures in 1893 and used it in print in 1894, replacing older terminology such as "mean error" and "error of mean square."

R. A. Fisher introduced the statistical term variance in his famous 1918 work on the resemblance between relatives, where variation could be decomposed into meaningful components.

Corrado Gini introduced his mean-difference approach to variability in 1912, providing an alternative family of ideas based on absolute pairwise differences rather than squared deviations.

So even historically, variance was never the only road through the forest.


4. A first experiment in Python

import numpy as np

x = np.array([1, 2, 3, 4, 20])

mean = np.mean(x)
median = np.median(x)
data_range = np.ptp(x)
variance = np.var(x, ddof=1)
sd = np.std(x, ddof=1)
iqr = np.percentile(x, 75) - np.percentile(x, 25)
mad_raw = np.median(np.abs(x - median))

print("Mean:", mean)
print("Median:", median)
print("Range:", data_range)
print("Variance:", variance)
print("SD:", sd)
print("IQR:", iqr)
print("MAD:", mad_raw)

Now remove the extreme observation:

y = np.array([1, 2, 3, 4])

for name, z in [("with outlier", x),
                ("without outlier", y)]:
    print("\n", name)
    print("SD =", np.std(z, ddof=1))
    print("IQR =", np.percentile(z, 75) -
                   np.percentile(z, 25))
    print("MAD =", np.median(
        np.abs(z - np.median(z))
    ))

The measures react very differently.

That reaction is not a bug. It tells us what each measure cares about.


5. The same experiment in R

x <- c(1, 2, 3, 4, 20)

mean(x)
median(x)
diff(range(x))
var(x)
sd(x)
IQR(x)

mad_raw <- median(abs(x - median(x)))
mad_raw

Compare with:

y <- c(1, 2, 3, 4)

metrics <- function(x) {
  c(
    SD = sd(x),
    IQR = IQR(x),
    MAD_raw = median(abs(x - median(x)))
  )
}

metrics(x)
metrics(y)

6. Properties we should demand from dispersion measures

A useful dispersion measure might possess several properties.

Non-negativity

[
D(X)\geq0.
]

Zero for constant data

If every observation is identical,

[
D(X)=0.
]

Translation invariance

Adding a constant should usually not change spread:

[
D(X+c)=D(X).
]

Variance, SD, IQR and MAD all satisfy this.

Scale equivariance

Multiplying the data by (a) should change a scale measure proportionally:

[
D(aX)=|a|D(X).
]

SD and MAD satisfy this.

Variance instead satisfies:

[
\operatorname{Var}(aX)=a^2\operatorname{Var}(X).
]

Robustness

How much can one pathological observation alter the answer?

This turns out to be one of the central questions in the entire series.


7. A crucial lesson

There is no universally best dispersion measure.

Choosing one involves deciding what kind of variation deserves influence.

Variance says:

Large deviations deserve disproportionately large influence.

MAD says:

The behavior of the majority matters more than extreme observations.

Range says:

I care specifically about the extremes.

IQR says:

I care about the central half.

Gini mean difference says:

I care about distances among all pairs.

Those are scientific choices disguised as formulas.

And that is why dispersion deserves more thought than simply typing sd(x).

What Should Science Learn From the Career Effects of Retractions?

Retractions are necessary.

That should be the starting point.

Scientific knowledge is valuable partly because science contains mechanisms for identifying and correcting unreliable claims. A literature in which papers can never be withdrawn would not be more trustworthy. It would be less trustworthy.

But the Nature Human Behaviour study shows that retraction systems do more than modify the literature.

They affect people.

The study's findings can be summarized as a sequence.

Retraction is associated with earlier departure from scientific publishing.

The effect appears particularly concerning for researchers with less-established careers.

Greater public attention surrounding a retraction is associated with a wider attrition gap.

Among researchers who remain, collaboration networks often grow rather than shrink.

Yet those networks change in composition, with important differences in collaborator seniority, productivity and impact.

What should institutions do with this information?

First, distinguish correction from culpability.

A retraction tells us something went wrong with a publication. It does not necessarily tell us that every author committed misconduct.

Second, make retraction notices more informative.

Readers should be able to distinguish honest error, plagiarism, fabrication, methodological failure and author-initiated correction whenever the evidence allows such distinctions.

Third, pay particular attention to junior researchers.

Because early-career scientists possess less accumulated reputational capital, institutions and mentors may need procedures ensuring that involvement in a retracted paper is evaluated according to actual contribution and responsibility.

Fourth, rethink how self-correction is rewarded.

If scientists believe voluntarily retracting erroneous work will permanently damage their careers, the system creates incentives to defend questionable results rather than correct them.

The authors themselves identify self-retraction, scientific-community support and changes in collaboration strategies as important mechanisms that future studies should examine.

Fifth, study the role of publicity.

A correction that receives almost no public attention and one that becomes an international scandal may have radically different career consequences. Future work needs to distinguish attention from condemnation and scientific discussion from personal exposure.

Finally, research integrity should be evaluated as a system rather than as a collection of individual retraction events.

The ideal system has to accomplish two things simultaneously:

correct science aggressively and assign responsibility accurately.

Those goals are not in conflict.

Indeed, both are necessary for a culture in which researchers are willing to acknowledge mistakes while deliberate misconduct remains consequential.

The deeper message of this study is therefore not that retractions are too harsh or too lenient.

It is that retraction is a much more powerful institutional intervention than simply placing a warning label on a PDF.

A retraction changes the scientific record.

It changes how researchers see one another.

It can reshape collaboration networks.

And, for some scientists, it can mark the point at which a publishing career ends.

Understanding those consequences is essential if science wants its mechanisms of self-correction to be both rigorous and fair.

Tuesday, September 22, 2026

Beyond the Standard Deviation

 

A Practical Series on Measuring Variability, Spread, and Statistical Dispersion

Most introductory statistics courses teach a familiar sequence:

mean → variance → standard deviation.

That sequence is useful, but it can accidentally suggest that once we know the standard deviation, the problem of measuring variability has been solved.

It has not.

There are many legitimate meanings of "spread":

  • How far apart are the extremes?
  • How wide is the central half of the data?
  • How far is a typical observation from the center?
  • How different are two randomly selected observations?
  • How variable is the quantity relative to its magnitude?
  • How much of the spread is caused by rare observations?
  • How dispersed is a multidimensional cloud?
  • What does dispersion even mean for angles, compositions, probability distributions, networks, images, or embeddings?

Different measures answer different questions.

This series explores those questions mathematically, historically, computationally, and practically.

The posts are:

  1. What Does "Spread" Actually Mean?
  2. Range, IQR, and Absolute Deviations
  3. Variance and Standard Deviation: Why Squaring Won
  4. Relative Dispersion: CV, Fano Factor, and Scale-Free Measures
  5. Robust Dispersion: MAD, Qn, Sn, and Gini Mean Difference
  6. Comparing Dispersion Between Groups
  7. Multivariate and High-Dimensional Dispersion
  8. When Ordinary Variance Stops Making Sense
  9. Where Dispersion Research Could Go Next